Skip Navigation

FDA Approves Leqembi, Extending Alzheimer’s Treatment to More Patients

www.wsj.com FDA Approves Leqembi, Extending Alzheimer’s Treatment to More Patients

Medicare enrollees can get the anti-amyloid treatment as a result of the agency’s full approval.

FDA Approves Leqembi, Extending Alzheimer’s Treatment to More Patients
7
7 comments
7 comments